Meeder Asset Management Inc Jazz Pharmaceuticals PLC Transaction History

Meeder Asset Management Inc

16 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	BUY	$126.59 - $161.18 $9,620 - $12,249	76 Added 155.1%	125 $17,000
Q2 2022 Aug 08, 2022	SELL	$141.59 - $168.66 $28,884 - $34,406	-204 Reduced 80.63%	49 $8,000
Q1 2022 May 10, 2022	SELL	$129.64 - $160.7 $2,852 - $3,535	-22 Reduced 8.0%	253 $39,000
Q4 2021 Feb 11, 2022	SELL	$119.87 - $145.67 $359 - $437	-3 Reduced 1.08%	275 $35,000
Q3 2021 Nov 08, 2021	SELL	$128.64 - $184.79 $124,523 - $178,876	-968 Reduced 77.69%	278 $36,000
Q2 2021 Aug 09, 2021	SELL	$160.2 - $186.42 $52,385 - $60,959	-327 Reduced 20.79%	1,246 $221,000
Q1 2021 Apr 28, 2021	BUY	$150.19 - $173.5 $229,640 - $265,281	1,529 Added 3475.0%	1,573 $259,000
Q4 2020 Feb 09, 2021	SELL	$140.71 - $165.05 $23,076 - $27,068	-164 Reduced 78.85%	44 $7,000
Q3 2020 Nov 02, 2020	SELL	$105.46 - $144.13 $198,053 - $270,676	-1,878 Reduced 90.03%	208 $29,000
Q2 2020 Aug 11, 2020	SELL	$95.68 - $121.88 $43,343 - $55,211	-453 Reduced 17.84%	2,086 $230,000
Q1 2020 May 15, 2020	BUY	$87.74 - $152.74 $2,807 - $4,887	32 Added 1.28%	2,539 $253,000
Q4 2019 Feb 13, 2020	BUY	$117.65 - $153.73 $4,000 - $5,226	34 Added 1.37%	2,507 $375,000
Q3 2019 Oct 17, 2019	SELL	$125.18 - $143.24 $3,755 - $4,297	-30 Reduced 1.2%	2,473 $317,000
Q2 2019 Aug 05, 2019	SELL	$125.55 - $144.48 $11,801 - $13,581	-94 Reduced 3.62%	2,503 $358,000
Q4 2018 Jan 17, 2019	SELL	$115.94 - $166.74 $38,723 - $55,691	-334 Reduced 11.4%	2,597 $321,000
Q3 2018 Nov 02, 2018	BUY	$161.01 - $180.57 $471,920 - $529,250	2,931 New	2,931 $0

512

57.5M

188K

133K

Ticker JAZZ
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 62,680,700
Market Cap $7.71B
Description
Jazz Pharmaceuticals plc, a biopharmaceutical company, identifies, develops, and commercializes pharmaceutical products for various unmet medical needs in the United States, Europe, and internationally. The company has a portfolio of products and product candidates with a focus in the areas of neuroscience, including sleep medicine and movement ...

Get notified when there are updates to the investment portfolio of Meeder Asset Management Inc, based on Form 13F filings with the SEC.

Stay updated on Meeder Asset Management Inc with notifications on news.